Anzeige
Mehr »
Login
Dienstag, 14.01.2025 Börsentäglich über 12.000 News von 681 internationalen Medien
Das 13-Millionen-Unternehmen mit einer Monster-Entdeckung!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40WD7 | ISIN: US81764X1037 | Ticker-Symbol:
NASDAQ
14.01.25
21:59 Uhr
95,75 US-Dollar
-4,25
-4,25 %
Branche
Software
Aktienmarkt
Sonstige
1-Jahres-Chart
SERVICETITAN INC Chart 1 Jahr
5-Tage-Chart
SERVICETITAN INC 5-Tage-Chart
GlobeNewswire (Europe)
225 Leser
Artikel bewerten:
(1)

ServiceTitan Announces Third Quarter Fiscal 2025 Financial Results

Finanznachrichten News

LOS ANGELES, Jan. 13, 2025 (GLOBE NEWSWIRE) -- ServiceTitan (NASDAQ: TTAN), the software platform that powers the trades, today announced financial results for the fiscal third quarter ended October 31, 2024.

"Building a generational business that is the operating system for the trades is our life's work," said Ara Mahdessian, co-founder and CEO. "We recognize that the only thing more exciting than how far we have come, is just how far we have yet to go. Healthy fiscal third quarter business performance is further evidence that our strategy is working."

"We are pleased to deliver fiscal third quarter financial performance ahead of the midpoint of our flash results," said Vahe Kuzoyan, co-founder and President. "Our customers are expanding well and we are pleased with strong early adoption of our new Sales Pro and Contact Center Pro products."

Third Quarter Fiscal 2025 Financial Highlights:

Revenue:

  • Total revenue increased 24% year-over-year to $199.3 million.
  • Platform revenue increased 26% year-over-year to $191.2 million.

Loss from Operations:

  • GAAP loss from operations was ($44.0) million for the third quarter of fiscal 2025, compared to ($36.1) million for the third quarter of fiscal 2024.
  • Non-GAAP income from operations was $1.6 million for the third quarter of fiscal 2025, compared to non-GAAP loss from operations of ($4.3) million for the third quarter of fiscal 20241.

Net Loss:

  • GAAP net loss was ($46.5) million for the third quarter of fiscal 2025, compared to ($39.7) million for the third quarter of fiscal 2024.
  • Non-GAAP net loss was ($1.1) million for the third quarter of fiscal 2025, compared to ($7.2) million for the third quarter of fiscal 20241.

Cash:

  • Cash and cash equivalents totaled $133.8 million as of October 31, 2024.
  • Net cash generated by operating activities was $15.5 million for the third quarter of fiscal 2025, compared to $0.4 million for the third quarter of fiscal 2024.
  • Non-GAAP free cash flow was $10.6 million for the third quarter of fiscal 2025, compared to ($6.2) million for the third quarter of fiscal 20241.

_________________________
1 This press release uses non-GAAP financial measures that adjust GAAP financial measures for the impact of various items. See the section titled "Non-GAAP Financial Measures" and the tables entitled "GAAP to Non-GAAP Reconciliation" below for additional information.


Business and Operational Highlights:

  • Net dollar retention was greater than 110% for the third quarter of fiscal 2025.
  • Gross Transaction Volume ("GTV") was $17.8 billion for the third quarter of fiscal 2025, up 20% year-over-year.

Fiscal Fourth Quarter and Fiscal Year 2025 Financial Outlook:
For the fourth quarter of fiscal 2025, the Company currently expects:

  • Total revenue in the range of $199.0 million to $201.0 million.
  • Non-GAAP income from operations in the range of $3.0 million to $4.0 million2.

For the full year fiscal 2025, the Company currently expects:

  • Total revenue in the range of $761.6 million to $763.6 million.
  • Non-GAAP income from operations in the range of $21.4 million to $22.4 million².

Conference Call Information:
The financial results and business highlights will be discussed on a conference call and webcast scheduled at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) on Monday, January 13, 2025. Online registration for this event conference call can be found here. The live webcast of the conference call can be accessed from ServiceTitan's investor relations website at http://investors.servicetitan.com.

Following completion of the events, a webcast replay will also be available at http://investors.servicetitan.com for 12 months.

About ServiceTitan
ServiceTitan is the software platform that powers trades businesses. The Company's cloud-based, end-to-end solution gives contractors the tools they need to run and grow their business, manage their back office, and provide a stellar customer experience. By bringing an integrated SaaS platform to an industry historically underserved by technology, ServiceTitan is equipping tradespeople with the technology they need to keep the world running.

_________________________
2 ServiceTitan is not able, at this time, to provide an outlook for GAAP income (loss) from operations or a reconciliation of expected non-GAAP income from operations to GAAP income (loss) from operations for the fourth quarter of fiscal 2025 or for the full fiscal year 2025 because of the difficulty of estimating certain items excluded from non-GAAP income from operations that cannot be reasonably calculated or predicted without unreasonable efforts. For example, charges related to stock-based compensation expense require additional inputs, such as the number and value of awards granted, that are not currently ascertainable.


Forward Looking Statements
This press release contains forward-looking statements within the meaning of the Securities Act of 1933, as amended, the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts contained in this press release may be forward-looking statements. In some cases, you can identify forward-looking statements because they contain words such as "anticipate," "believe," "contemplate," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential" "predict," "project," "should," "target," or "will," or the negative of these words or other similar terms or expressions that concern ServiceTitan's expectations, strategy, plans or intentions. Forward-looking statements in this release include, but are not limited to, statements regarding ServiceTitan's financial outlook for total revenue and non-GAAP income from operations for the fourth quarter of fiscal year 2025 ending January 31, 2025 and the full fiscal year ending January 31, 2025. ServiceTitan's expectations and beliefs regarding these matters may not materialize, and actual results in future periods are subject to risks and uncertainties that could cause actual results to differ materially from those projected, including those more fully described under the caption "Risk Factors" in our Prospectus dated December 11, 2024, filed with the SEC on December 12, 2024, and elsewhere in documents that ServiceTitan files with the SEC, including ServiceTitan's Quarterly Report on Form 10-Q for the fiscal third quarter ended October 31, 2024, which is being filed with the SEC at or around the date hereof. The forward-looking statements in this release are based on information available to ServiceTitan as of the date hereof, and ServiceTitan undertakes no obligation to update any forward-looking statements, except as required by law.

© 2025 ServiceTitan. All rights reserved. ServiceTitan, the ServiceTitan logo, and all ServiceTitan product and service names mentioned herein are registered trademarks or unregistered trademarks of ServiceTitan, Inc. in the United States and other countries. Other brand names and marks mentioned herein are for identification purposes only and may be the trademarks of their respective holder(s).

ServiceTitan, Inc.
Condensed Consolidated Statements of Operations
(in thousands, except share and per share data)
(unaudited)
Three Months Ended October 31, Nine Months Ended October 31,
2024 2023 2024 2023
Revenue:
Platform $191,190 $151,655 $539,412 $427,789
Professional services and other 8,085 8,429 23,185 24,788
Total revenue 199,275 160,084 562,597 452,577
Cost of revenue:
Platform 52,204 42,036 149,197 125,939
Professional services and other 17,126 15,280 50,649 50,220
Total cost of revenue 69,330 57,316 199,846 176,159
Gross profit 129,945 102,768 362,751 276,418
Operating expenses:
Sales and marketing 67,795 60,097 183,614 163,305
Research and development 65,935 49,094 186,997 149,114
General and administrative 40,263 29,723 122,226 98,772
Total operating expenses 173,993 138,914 492,837 411,191
Loss from operations (44,048) (36,146) (130,086) (134,773)
Other expense, net
Interest expense (3,974) (4,216) (12,324) (12,203)
Interest income 1,778 1,978 5,128 5,095
Other income (expense), net 185 (258) 395 1,091
Total other expense, net (2,011) (2,496) (6,801) (6,017)
Loss before income taxes (46,059) (38,642) (136,887) (140,790)
Provision for income taxes 401 1,030 1,264 2,943
Net loss (46,460) (39,672) (138,151) (143,733)
Accretion of non-convertible preferred stock (14,652) (11,772) (41,608) (33,390)
Net loss attributable to common stockholders $(61,112) $(51,444) $(179,759) $(177,123)
Net loss per share, basic and diluted $(1.74) $(1.53) $(5.18) $(5.36)
Weighted-average shares used in computing net loss per share, basic and diluted 35,094,547 33,588,617 34,690,079 33,043,071
Disaggregated Revenue
Three Months Ended October 31, Nine Months Ended October 31,
2024 2023 2024 2023
Subscription $145,282 $114,311 $409,013 $322,086
Usage 45,908 37,344 130,399 105,703
Platform revenue 191,190 151,655 539,412 427,789
Professional services and other 8,085 8,429 23,185 24,788
Total revenue $199,275 $160,084 $562,597 $452,577
ServiceTitan, Inc.
Condensed Consolidated Balance Sheets
(in thousands, except share and per share data)
(unaudited)
As of
October 31, January 31,
2024 2024
Assets
Current assets:
Cash and cash equivalents $133,811 $146,710
Restricted cash 692 1,403
Accounts receivable, net of allowance of $5,929 and $3,762 as of October 31, 2024 and January 31, 2024, respectively 41,218 28,046
Deferred contract costs, current 10,721 9,451
Contract assets 43,964 39,329
Prepaid expenses 18,813 22,652
Other current assets 3,370 1,640
Total current assets 252,589 249,231
Restricted cash, noncurrent 583 750
Deferred contract costs, noncurrent 9,277 8,399
Property and equipment, net 60,124 97,170
Operating lease right-of-use assets 25,572 43,270
Internal-use software, net 35,842 29,300
Intangible assets, net 226,394 251,347
Goodwill 845,836 830,872
Other assets 11,927 7,327
Total assets $1,468,144 $1,517,666
Liabilities, Non-Convertible Preferred Stock, Redeemable Convertible Preferred Stock and Stockholders' Deficit
Current liabilities:
Accounts payable and other accrued expenses $45,306 $45,293
Accrued personnel related expenses 64,737 55,321
Deferred revenue, current 16,022 11,160
Operating lease liabilities, current 11,710 11,005
Short-term debt 1,073 1,800
Other current liabilities 1,133 688
Total current liabilities 139,981 125,267
Operating lease liabilities, noncurrent 50,201 58,576
Long-term debt, net 174,169 174,578
Other noncurrent liabilities 9,531 7,684
Total liabilities 373,882 366,105
Commitments and contingencies
Non-Convertible Preferred Stock
Non-convertible preferred stock, par value $0.001, 250,000 authorized, issued and outstanding as of October 31, 2024 and January 31, 2024. Liquidation preference of $307,005 as of October 31, 2024 275,154 233,546
Redeemable Convertible Preferred Stock
Redeemable convertible preferred stock, par value $0.001, 42,465,855 shares authorized, issued and outstanding as of October 31, 2024 and January 31, 2024. Liquidation preference of $1,398,054 as of October 31, 2024 1,395,878 1,395,878
Stockholders' Deficit
Common stock, par value $0.001, 94,490,000 and 92,630,000 shares authorized as of October 31, 2024 and January 31, 2024, respectively. 35,397,085 shares and 34,185,388 shares issued and outstanding as of October 31, 2024 and January 31, 2024, respectively 35 34
Additional paid-in capital 427,982 388,739
Accumulated deficit (1,004,787) (866,636)
Total stockholders' deficit (576,770) (477,863)
Total liabilities, non-convertible preferred stock, redeemable convertible preferred stock and stockholders' deficit $1,468,144 $1,517,666
ServiceTitan, Inc.
Condensed Consolidated Statements of Cash Flows
(in thousands)
(unaudited)
Three Months Ended October 31, Nine Months Ended October 31,
2024 2023 2024 2023
Cash flows provided by (used in) operating activities
Net loss $(46,460) $(39,672) $(138,151) $(143,733)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities
Depreciation and amortization expense 20,229 19,986 59,836 57,997
Amortization of deferred contract costs 2,971 2,433 8,364 6,865
Noncash operating lease expense 1,539 1,955 4,946 5,884
Stock-based compensation expense 25,426 19,462 69,050 72,037
Loss on impairment and disposal of assets 8,312 431 38,586 604
Change in valuation of contingent consideration - - (135) (900)
Deferred income taxes 133 784 1,254 1,647
Amortization of debt issuance costs 87 39 214 93
Provision for credit losses 976 857 2,816 1,636
Changes in operating assets and liabilities, net of effect of business acquisition:
Accounts receivable (2,480) 2,330 (13,563) (6,346)
Prepaid expenses and other current assets 6,614 (164) 3,260 1,179
Deferred contract costs (4,802) (3,207) (10,511) (9,070)
Contract assets (2,186) (3,959) (4,635) (9,277)
Other assets (875) (564) (532) (686)
Accounts payable and other accrued expenses (4,717) (2,893) (4,434) (3,475)
Accrued personnel related expenses 12,505 2,534 9,119 (13,381)
Operating lease liabilities (3,953) (2,010) (7,830) (6,062)
Other liabilities 925 1,097 1,421 (1,567)
Deferred revenue 1,290 979 2,551 991
Net cash provided by (used in) operating activities 15,534 418 21,626 (45,564)
Cash flows used in investing activities
Capitalized internal-use software (3,961) (3,784) (14,161) (12,831)
Purchase of property and equipment (1,002) (2,786) (2,803) (23,401)
Deposits for property and equipment - (54) - (344)
Repayment of loan to employee - - - 1,529
Acquisition of business, net of cash acquired - - (1,184) -
Net cash used in investing activities (4,963) (6,624) (18,148) (35,047)
Cash flows provided by (used in) financing activities
Payment of contingent consideration - (120) (300) (610)
Proceeds from exercise of stock options 1,093 1,323 4,307 8,044
Proceeds from issuance of preferred stock - - - 34,000
Payment of preferred stock issuance costs - - - (409)
Payment of debt arrangements (450) (450) (1,350) (900)
Payment of deferred initial public offering costs (106) - (949) -
Shares repurchased for tax withholding for the settlement of restricted stock units (5,398) (9,506) (18,963) (11,992)
Net cash provided by (used in) financing activities (4,861) (8,753) (17,255) 28,133
Net increase (decrease) in cash, cash equivalents, and restricted cash 5,710 (14,959) (13,777) (52,478)
Cash, cash equivalents, and restricted cash
Beginning of period 129,376 167,124 148,863 204,643
End of period $135,086 $152,165 $135,086 $152,165

Non-GAAP Financial Measures
In addition to our results prepared in accordance with GAAP, we believe non-GAAP gross profit and non-GAAP gross margin in total and for platform and professional services and other, non-GAAP sales and marketing expense, non-GAAP research and development expense, non-GAAP general and administrative expense, non-GAAP income (loss) from operations, non-GAAP operating margin, and non-GAAP net income (loss) are useful in evaluating our operating performance.

These measures, however, have certain limitations in that they reflect the exercise of judgment by our management about which expenses are excluded or included and do not include the impact of certain expenses that are reflected in our consolidated statement of operations that are necessary to run our business. These non-GAAP financial measures should be considered in addition to, not as a substitute for or in isolation from, our financial results determined in accordance with GAAP. We caution investors that amounts presented in accordance with our definition of non-GAAP gross profit, non-GAAP gross margin, non-GAAP sales and marketing expense, non-GAAP research and development expense, non-GAAP general and administrative expense, non-GAAP income (loss) from operations, non-GAAP operating margin and non-GAAP net income (loss) may not be comparable to similar measures disclosed by other companies because not all companies and analysts calculate these measures in the same manner.

For the reasons set forth below, we believe that excluding the following items provides information that is helpful in understanding our operating results, evaluating our future prospects, comparing our financial results across accounting periods, and comparing our financial results to our peers, many of which provide similar non-GAAP financial measures.

  • Stock-based compensation expense and related employer payroll taxes. We exclude stock-based compensation expense and related employer payroll taxes to allow investors to make more meaningful comparisons of our performance between periods and to facilitate a comparison of our performance to those of other peer companies. Stock-based compensation may vary between periods due to various factors unrelated to our core performance, including as a result of the assumptions used in the valuation methodologies, timing and amount of grants and other factors. We exclude employer payroll taxes because the amounts vary based on timing and settlement or vesting of awards unrelated to our core operating performance. Moreover, stock-based compensation expense is a non-cash expense that we exclude from our internal management reporting processes and when assessing our actual performance, budgeting, planning, and forecasting future periods.
  • Amortization of acquired intangible assets. We incur amortization expense for acquired intangible assets in connection with acquisitions of certain businesses and technologies. Amortization of acquired intangible assets is a non-cash expense that is significantly affected by the timing and size of acquisitions, and the inherent subjective nature of purchase price allocations. Because these costs have already been incurred, we exclude the amortization expense from our internal management reporting processes. We exclude these charges when assessing our actual performance and when budgeting, planning, and forecasting future periods. Investors should note that the use of intangible assets contributed to our revenues earned during the periods presented and will contribute to our future period revenues as well.
  • Restructuring charges. To better align our strategic priorities with our investments, we implemented workforce reductions in fiscal 2024 and fiscal 2025. In connection with these reductions, we incurred employee-related expenses including severance and other termination benefits. We excluded these charges when assessing our actual performance and when budgeting, planning and forecasting future periods.
  • Loss on operating lease assets. In fiscal 2024 and fiscal 2025, we incurred impairments on certain right-of-use assets and other long-lived assets. We believe that it is useful to exclude these charges when assessing the level of various operating expenses and resource allocations when budgeting, planning and forecasting future periods. In addition, we believe excluding such costs enhances the comparability between periods.
  • Acquisition-related items. We have incurred costs related to acquisitions, including legal, third-party valuation and due diligence, insurance costs, and one-time retention bonuses for employees of acquired companies. In addition, we periodically record the change to the fair value of contingent consideration related to past acquisitions. We exclude these items when assessing our actual performance and when budgeting, planning and forecasting future periods. We believe excluding these items allows investors to make meaningful comparisons between our core operating results and those of other peer companies.

Free Cash Flow

We define free cash flow as net cash provided by (used in) operating activities less cash used for investing activities for capitalized internal use software and less cash paid for purchases of, and deposits for, property and equipment. We believe that free cash flow is a meaningful indicator of our sources of liquidity and capital requirements that provides information to management and investors in evaluating the cash flow trends of our business. Once our business needs and obligations are met, cash can be used to maintain a strong balance sheet and invest in future growth. Free cash flow has limitations as an analytical tool and should not be considered in isolation or as a substitute for analysis of our results as reported under GAAP. Other companies may calculate free cash flow or similarly titled non-GAAP measures differently, which could reduce the usefulness of free cash flow as a tool for comparison. In addition, free cash flow does not reflect mandatory debt service and other non-discretionary expenditures that are required to be made under contractual commitments and does not represent the total increase or decrease in our cash balance for any given period.

ServiceTitan, Inc.
GAAP to Non-GAAP Reconciliations
(unaudited)
Non-GAAP Gross Profit and Non-GAAP Gross Margin
Platform Professional
Services and Other
Total
Three Months Ended
October 31,
Three Months Ended
October 31,
Three Months Ended
October 31,
2024 2023 2024 2023 2024 2023
(in thousands)
GAAP gross profit $138,986 $109,619 $(9,041) $(6,851) $129,945 $102,768
Stock-based compensation expense and related employer payroll taxes 1,634 1,399 1,159 1,102 2,793 2,501
Amortization of acquired intangible assets 5,533 5,502 334 484 5,867 5,986
Restructuring charges - - - - - -
Loss on operating lease assets 1,189 - 563 - 1,752 -
Non-GAAP gross profit $147,342 $116,520 $(6,985) $(5,265) $140,357 $111,255
Platform Professional
Services and Other
Total
Three Months Ended
October 31,
Three Months Ended
October 31,
Three Months Ended
October 31,
2024 2023 2024 2023 2024 2023
GAAP gross margin 73% 72% (112)% (81)% 65% 64%
Stock-based compensation expense and related employer payroll taxes 1% 1% 14% 13% 1% 2%
Amortization of acquired intangible assets 3% 4% 4% 6% 3% 4%
Restructuring charges 0% 0% 0% 0% 0% 0%
Loss on operating lease assets 1% 0% 7% 0% 1% 0%
Non-GAAP gross margin 77% 77% (86)% (62)% 70% 69%
Platform Professional
Services and Other
Total
Nine Months Ended
October 31,
Nine Months Ended
October 31,
Nine Months Ended
October 31,
2024 2023 2024 2023 2024 2023
(in thousands)
GAAP gross profit $390,215 $301,850 $(27,464) $(25,432) $362,751 $276,418
Stock-based compensation expense and related employer payroll taxes 4,161 4,361 3,165 3,436 7,326 7,797
Amortization of acquired intangible assets 16,369 16,506 1,452 1,452 17,821 17,958
Restructuring charges 386 1,160 129 1,969 515 3,129
Loss on operating lease assets 5,390 - 2,556 - 7,946 -
Non-GAAP gross profit $416,521 $323,877 $(20,162) $(18,575) $396,359 $305,302
Platform Professional
Services and Other
Total
Nine Months Ended
October 31,
Nine Months Ended
October 31,
Nine Months Ended
October 31,
2024 2023 2024 2023 2024 2023
GAAP gross margin 72% 71% (118)% (103)% 64% 61%
Stock-based compensation expense and related employer payroll taxes 1% 1% 14% 14% 1% 2%
Amortization of acquired intangible assets 3% 4% 6% 6% 3% 4%
Restructuring charges 0% 0% 1% 8% 0% 1%
Loss on operating lease assets 1% 0% 11% 0% 1% 0%
Non-GAAP gross margin 77% 76% (87)% (75)% 70% 67%


Non-GAAP Sales and Marketing Expense

Three Months Ended October 31, Nine Months Ended October 31,
2024 2023 2024 2023
(in thousands)
GAAP sales and marketing expense $67,795 $60,097 $183,614 $163,305
Stock-based compensation expense and related employer payroll taxes (4,132) (4,419) (11,776) (14,305)
Amortization of acquired intangible assets (5,606) (5,547) (16,662) (17,033)
Restructuring charges - - (292) (1,647)
Loss on operating lease assets (1,467) - (6,900) -
Non-GAAP sales and marketing expense $56,590 $50,131 $147,984 $130,320


Non-GAAP Research and Development Expense

Three Months Ended October 31, Nine Months Ended October 31,
2024 2023 2024 2023
(in thousands)
GAAP research and development expense $65,935 $49,094 $186,997 $149,114
Stock-based compensation expense and related employer payroll taxes (10,451) (7,621) (28,060) (25,023)
Acquisition-related items - - (250) -
Restructuring charges - - (991) (1,418)
Loss on operating lease assets (1,468) - (6,711) -
Non-GAAP research and development expense $54,016 $41,473 $150,985 $122,673


Non-GAAP General and Administrative Expense

Three Months Ended October 31, Nine Months Ended October 31,
2024 2023 2024 2023
(in thousands)
GAAP general and administrative expense $40,263 $29,723 $122,226 $98,772
Stock-based compensation expense and related employer payroll taxes (8,408) (5,789) (23,600) (26,713)
Acquisition-related items (6) 10 (1,933) 893
Restructuring charges - - (698) (1,449)
Loss on operating lease assets (3,660) - (16,958) -
Non-GAAP general and administrative expense $28,189 $23,944 $79,037 $71,503


Non-GAAP Income (Loss) from Operations and Non-GAAP Operating Margin

Three Months Ended October 31, Nine Months Ended October 31,
2024 2023 2024 2023
(in thousands)
GAAP loss from operations $(44,048) $(36,146) $(130,086) $(134,773)
Stock-based compensation expense and related employer payroll taxes 25,784 20,330 70,762 73,838
Amortization of acquired intangible assets 11,473 11,533 34,483 34,991
Restructuring charges - - 2,496 7,643
Acquisition-related items 6 (10) 2,183 (893)
Loss on operating lease assets 8,347 - 38,515 -
Non-GAAP income (loss) from operations $1,562 $(4,293) $18,353 $(19,194)
Three Months Ended October 31,
Nine Months Ended October 31,
2024 2023 2024 2023
GAAP operating margin (22)% (23)% (23)% (30)%
Stock-based compensation expense and related employer payroll taxes 13% 13% 13% 16%
Amortization of acquired intangible assets 6% 7% 6% 8%
Restructuring charges 0% 0% 0% 2%
Acquisition-related items 0% (0)% 0% (0)%
Loss on operating lease assets 4% 0% 7% 0%
Non-GAAP operating margin 1% (3)% 3% (4)%


Non-GAAP Net Income (Loss)

Three Months Ended October 31, Nine Months Ended October 31,
2024 2023 2024 2023
(in thousands)
GAAP net loss $(46,460) $(39,672) $(138,151) $(143,733)
Stock-based compensation expense and related employer payroll taxes 25,784 20,330 70,762 73,838
Amortization of acquired intangible assets 11,473 11,533 34,483 34,991
Restructuring charges - - 2,496 7,643
Acquisition-related items 6 (10) 2,183 (893)
Loss on operating lease assets 8,347 - 38,515 -
Income tax effects related to the above adjustments (1) (298) 632 (1,207) 1,508
Non-GAAP net income (loss) $(1,148) $(7,187) $9,081 $(26,646)

(1) This amount represents adjustments for the current and deferred income tax effects on non-GAAP net income (loss) for the impact of the non-GAAP adjustments above.


Free Cash Flow

Three Months Ended October 31, Nine Months Ended October 31,
2024 2023 2024 2023
(in thousands)
Net cash provided by (used in) operating activities $15,534 $418 $21,626 $(45,564)
Capitalized internal-use software (3,961) (3,784) (14,161) (12,831)
Purchase of property and equipment (1,002) (2,786) (2,803) (23,401)
Deposits for property and equipment - (54) - (344)
Non-GAAP free cash flow $10,571 $(6,206) $4,662 $(82,140)


© 2025 GlobeNewswire (Europe)
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.